Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00006031 · ClinicalTrials.gov registry record · NA

Comparison of Two Types of Biopsy in Patients With Breast Lesions

A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
NA
Development phase
117
Enrollment target

NCT00006031 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 117 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00006031, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
NA
Development phase
117 participants
Enrollment target

Study Summary

RATIONALE: Biopsy is the removal of cells or tissue for examination under a microscope. It is not yet known which type of breast biopsy is more effective for diagnosing breast lesions. PURPOSE: Randomized diagnostic trial to compare the effectiveness of two different types of biopsy in patients who have breast lesions that cannot be felt upon examination.

Interventions

  • PROCEDURE Needle localized breast biopsy with specimen x-ray
  • PROCEDURE Low dose radioactive seed followed by surgery and mammogram

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 1999-11
Est. Completion 2006-07
Phase NA

What the Registry Record Tells You About NCT00006031

The ClinicalTrials.gov registry entry for NCT00006031 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Needle localized breast biopsy with specimen x-ray is the first listed.

NCT00006031 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00006031 about?

NCT00006031 is a clinical study titled "Comparison of Two Types of Biopsy in Patients With Breast Lesions". RATIONALE: Biopsy is the removal of cells or tissue for examination under a microscope. It is not yet known which type of breast biopsy is more effective for diagnosing breast lesions. PURPOSE: Randomized diagnostic trial to compare the effectiveness of two different types of biopsy in patients who...

What is the current status of trial NCT00006031?

This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 1999-11. Estimated completion is 2006-07.

What interventions are being tested in trial NCT00006031?

The interventions under investigation include: Needle localized breast biopsy with specimen x-ray (PROCEDURE), Low dose radioactive seed followed by surgery and mammogram (PROCEDURE).

Who is sponsoring clinical trial NCT00006031?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.